Lijekovi

Poremećaj opskrbe: u vezi s potražnjom

Razlog „u vezi s potražnjom” naveden je u 14 prijava poremećaja opskrbe, od toga 0 aktivnih.

14prijava
0aktivnih
2nositelja
14na receptu
14 od 14 prijava s ovim razlogom
LijekDjelatna tvarPakiranjeNositeljPočetakPlanirani prestanak
Flixotide 125 inhalerflutikazonstlač. inhalat, susp. 60x1GlaxoSmithKline Trading Se02.08.2023.08.09.2023.
Flixotide 250 inhalerflutikazonstlač. inhalat, susp. 60x2GlaxoSmithKline Trading Se02.08.2023.06.09.2023.
Lamictallamotrigintbl. za žvak./oral. susp. GlaxoSmithKline Trading Se02.08.2023.04.10.2023.
Avamysflutikazon furoatsprej za nos, boč. 1x120 dGlaxoSmithKline (Ireland) 06.04.2023.05.08.2023.
Lamictallamotrigintbl. za žvak./oral. susp. GlaxoSmithKline Trading Se08.01.2024.21.02.2024.
Imigransumatriptantbl. 2x50 mgGlaxoSmithKline Trading Se08.01.2024.09.01.2025.
Augmentinamoksicilin + klavulansktbl. film obl. 14x1 g (875GlaxoSmithKline Trading Se12.04.2024.27.05.2024.
Flixotide 125 inhalerflutikazonstlač. inhalat, susp. 60x1GlaxoSmithKline Trading Se12.04.2024.17.04.2024.
Flixotide inhalerflutikazonstlač. inhalat, susp. 120xGlaxoSmithKline Trading Se12.04.2024.29.05.2024.
Flixotide 125 inhalerflutikazonstlač. inhalat, susp. 60x1GlaxoSmithKline Trading Se20.04.2023.24.05.2023.
Avamysflutikazon furoatsprej za nos, boč. 1x120 dGlaxoSmithKline (Ireland) 21.09.2023.11.03.2024.
Flixotide inhalerflutikazonstlač. inhalat, susp. 120xGlaxoSmithKline Trading Se21.09.2023.22.01.2024.
Augmentinamoksicilin + klavulansksusp. 70 ml(400 mg +57 mg)GlaxoSmithKline Trading Se23.04.2024.07.06.2024.
Flixotide 125 inhalerflutikazonstlač. inhalat, susp. 60x1GlaxoSmithKline Trading Se24.07.2024.11.09.2024.

Pogođene djelatne tvari

Nositelji s ovim razlogom

Drugi razlozi